TW349866B - A pharmaceutical composition to provide an orally administrable cholesterol lowering action - Google Patents

A pharmaceutical composition to provide an orally administrable cholesterol lowering action

Info

Publication number
TW349866B
TW349866B TW083107074A TW83107074A TW349866B TW 349866 B TW349866 B TW 349866B TW 083107074 A TW083107074 A TW 083107074A TW 83107074 A TW83107074 A TW 83107074A TW 349866 B TW349866 B TW 349866B
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
cholesterol lowering
lowering action
orally administrable
weight
Prior art date
Application number
TW083107074A
Other languages
English (en)
Inventor
Tatsuo Nomura
Original Assignee
Mitsubishi Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Corp filed Critical Mitsubishi Chem Corp
Application granted granted Critical
Publication of TW349866B publication Critical patent/TW349866B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW083107074A 1993-08-03 1994-08-02 A pharmaceutical composition to provide an orally administrable cholesterol lowering action TW349866B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19239293 1993-08-03

Publications (1)

Publication Number Publication Date
TW349866B true TW349866B (en) 1999-01-11

Family

ID=16290545

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083107074A TW349866B (en) 1993-08-03 1994-08-02 A pharmaceutical composition to provide an orally administrable cholesterol lowering action

Country Status (9)

Country Link
US (1) US5447726A (zh)
EP (1) EP0637447B1 (zh)
KR (1) KR100322340B1 (zh)
CN (1) CN1069518C (zh)
AT (1) ATE175111T1 (zh)
CA (1) CA2129079C (zh)
DE (1) DE69415601T2 (zh)
ES (1) ES2128471T3 (zh)
TW (1) TW349866B (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69705877T2 (de) * 1996-03-05 2002-06-06 Mitsubishi Chem Corp Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie
US6066336A (en) * 1997-09-29 2000-05-23 Bristol-Myers Squibb Company Cholesterol-lowering tablets
JP2001115022A (ja) * 1999-10-18 2001-04-24 Shin Etsu Chem Co Ltd 室温硬化性オルガノポリシロキサン組成物
US6733780B1 (en) * 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
CN1250205C (zh) * 2000-09-06 2006-04-12 三菱制药株式会社 口服颗粒制剂
WO2002043761A1 (fr) * 2000-11-28 2002-06-06 Mitsubishi Pharma Corporation Agents anti-obesite et aliments dietetiques
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
JP4353414B2 (ja) * 2001-07-30 2009-10-28 田辺三菱製薬株式会社 食後過血糖改善剤
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7459502B2 (en) * 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
CA2551528A1 (en) * 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
WO2007027566A2 (en) 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
JP5595660B2 (ja) 2005-09-15 2014-09-24 ジェンザイム コーポレーション アミンポリマー用サシェ製剤
JP5301273B2 (ja) * 2006-08-09 2013-09-25 田辺三菱製薬株式会社 錠剤
BRPI0717545A2 (pt) 2006-09-29 2013-10-22 Gezyme Corp Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS607652B2 (ja) * 1976-06-12 1985-02-26 三菱油化株式会社 陰イオン交換体の製造法
GB1573487A (en) * 1977-05-23 1980-08-28 Bristol Myers Co Bile acid binding composition
DE3272059D1 (en) * 1982-01-18 1986-08-28 Mitsubishi Petrochemical Co Cholesterol lowering drug
JPS60209523A (ja) * 1984-04-03 1985-10-22 Mitsubishi Petrochem Co Ltd コレステロ−ル低下剤
US4956182A (en) * 1989-03-16 1990-09-11 Bristol-Myers Company Direct compression cholestyramine tablet and solvent-free coating therefor
JPH02286621A (ja) * 1989-04-26 1990-11-26 Mitsubishi Kasei Corp 経口コレステロール低下剤
EP0497985B1 (en) * 1990-08-24 1998-07-22 Shin-Etsu Chemical Co., Ltd. Coating base for pharmaceutical film and production thereof
WO1993000915A1 (en) * 1991-07-03 1993-01-21 The Upjohn Company Colestipol hydrochloride high-content tablets
JPH06157325A (ja) * 1992-11-30 1994-06-03 Mitsubishi Kasei Corp 経口コレステロール低下剤

Also Published As

Publication number Publication date
ATE175111T1 (de) 1999-01-15
DE69415601T2 (de) 1999-07-22
CA2129079C (en) 2006-01-17
KR100322340B1 (ko) 2002-06-20
US5447726A (en) 1995-09-05
EP0637447A3 (en) 1995-05-24
CN1069518C (zh) 2001-08-15
EP0637447B1 (en) 1998-12-30
CA2129079A1 (en) 1995-02-04
EP0637447A2 (en) 1995-02-08
CN1107334A (zh) 1995-08-30
DE69415601D1 (de) 1999-02-11
KR950005316A (ko) 1995-03-20
ES2128471T3 (es) 1999-05-16

Similar Documents

Publication Publication Date Title
TW349866B (en) A pharmaceutical composition to provide an orally administrable cholesterol lowering action
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
GR3036816T3 (en) Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
CA2161641A1 (en) Stable, ingestable and absorbable nadh and nadph therapeutic compositions
GR3034214T3 (en) Non-crosslinked anion exchange resin and pharmaceutical composition containing same
ZA937112B (en) 17-aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstaniene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions contning same
CA2090220A1 (en) Treatment of non-inflammatory and non-infectious bowel disorders
IE820856L (en) Omega-cyano-1,omega-diphenyl-azaalkane derivatives.
KR860000865A (ko) 약제 제형의 제조방법
ES8702427A1 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
DE3365785D1 (en) Pharmaceutically active copolymers, process for their preparation and pharmaceutical compositions containing them
JPS52128210A (en) Preparation of soft capsule for 1alpha-hydroxyvitamind derivatives
CA2111083A1 (en) Novel peptides, their preparation and use
CA2041831A1 (en) N-glycidyl compound
CA2047802A1 (en) Pharmaceutical compositions
EP0462948A3 (en) Pharmaceutical compositions comprising 3-amino-epsilon-caprolactames for enhancing learning and memory
EP0661050A4 (en) ANALGESIC.
EP0564648A4 (en) Novel aconitine compound and analgesic/antiinflammatory agent.
MY117887A (en) Phenyl-substituted 1, 4 - dihydropyridines
WO2001064203A3 (en) Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q¿10?
JPS52151732A (en) Prophylactic and therapeutic agent against bacterial
MX9703839A (es) Soluciones intravenosas de lubeluzol.
IE42475L (en) Biphenylyl ethers
IT8119746A0 (it) N,n'-bis (2-idrossi-e 2,3-diidrossibenzoli)-d,w-di e triami-noalcani come prodotti farmaceutici per chelare il ferro attivi per via orale.

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent